HCA HCA Healthcare, Inc. Common Stock
NYSE · Health Care · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Jul 28, 2026HCA Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
HCA Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Acerca de HCA Healthcare, Inc. Common Stock Descripción general de la empresa de Wikipedia
HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.
History
Early years
The Hospital Corporation of America (HCA) was founded in 1968 in Nashville, Tennessee, by Thomas F. Frist Sr., Thomas F. Frist Jr. and Jack C. Massey. The founders envisioned a company that would bring together hospitals to deliver patient-focused care while using the combined resources of the organization to strengthen hospitals and improve the practice of medicine. The company began with Nashville's Park View Hospital, which the elder Frist had founded in 1960 with other doctors and where he was chief executive.
The company included 11 hospitals when it filed its initial public offering on the New York Stock Exchange (NYSE) in 1969 and had 26 hospitals and 3,000 beds by the end of the year.
Growth and merger
The 1970s were characterized by rapid growth in the industry and for HCA Healthcare. In the early 1980s, the focus shifted to consolidation with HCA Healthcare acquiring General Care Corporation, General Health Services, Hospital Affiliates International and Health Care Corporation. By the end of 1981, the company operated 349 hospitals with more than 49,000 beds. Operating revenues had grown to $2.4 billion.
In 1987, HCA Healthcare, which had grown to operate 463 hospitals (255 owned and 208 managed), spun off HealthTrust, a privately owned, 104-hospital company. Believing its stock was undervalued, the company completed a $5.1 billion leveraged management buyout led by chairman Thomas F. Frist Jr. in 1988. HCA Healthcare re-emerged as a public company in 1992.
In February 1994, HCA Healthcare merged with Louisville, Kentucky-based Columbia Hospital Corporation, which earlier had acquired 73 hospitals of Galen Health Care from Humana,
to form Columbia/HCA Healthcare Corporation. Related names of note include HCA International and Health Corporation of America.
Columbia Hospital Corporation
In 1988, Rick Scott and Richard Rainwater each put up $125,000 in working capital in their new company, Columbia Hospital Corporation; they borrowed the remaining money needed to purchase two struggling hospitals in El Paso for $60 million. Then they acquired a neighboring hospital and shut it down. Within a year, the remaining two were doing much better. By the end of 1989, Columbia Hospital Corporation owned four hospitals with a total of 833 beds.
In 1992, Columbia made a stock purchase of Basic American Medical, which owned eight hospitals, primarily in southwestern Florida. In September 1993, Columbia did another stock purchase, worth $3.4 billion, of Galen Healthcare, which had been spun off by Humana Inc. several months earlier. At the time, Galen had approximately 90 hospitals. After the purchase, Galen stockholders had 82% of the stock in the combined company, with Scott still running the company.
Recent history
On November 17, 2006, HCA became a private company for the third time when it completed a merger in which the company was acquired by a private investor group including affiliates of Kohlberg Kravis Roberts and Bain Capital, together with Merrill Lynch and HCA Healthcare founder Thomas F. Frist Jr. The total transaction was valued at approximately $33 billion, making it the largest leveraged buyout in history at the time, eclipsing the 1989 buyout of RJR Nabisco.
In May 2010, HCA announced that the corporation would once again go public with an expected $4.6-billion IPO as HCA Holdings, Inc. In March 2011, HCA sold 126.2 million shares for $30 each, raising about $3.79 billion, at that time, the largest private-equity backed IPO in U.S. history. In May 2017, the corporation was renamed HCA Healthcare.
In December 2018, a historical marker was installed in the parking lot of HCA's Sarah Cannon Cancer Center in Nashville, formerly the location of HCA's first hospital, Park View Hospital.
In 2018, the company was ranked No. 67 in the 2019 Fortune 500 list of the largest United States corporations by total revenue.
In May 2021, the company finalized a deal with Google to develop healthcare algorithms using patient records. In August 2021, HCA announced a deal with venture capital firm General Catalyst to develop digital solutions to streamline workflows and improve patient care; as part of the deal, HCA sold its healthcare app development firm PatientKeeper to General Catalyst's portfolio company Commure.
In April 2022, HCA Healthcare announced a $1.5 million partnership with Florida International University's Nicole Wertheim college of Nursing and Health Sciences, to expand its facilities to address the national nursing shortage.
In October 2022, LCMC Health in partnership with Tulane University announced that it would acquire Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital from HCA for $150 million pending regulatory approval.
In March 2024, it was announced HCA had completed the sale of West Hills Hospital and Medical Center and related assets in Los Angeles, California to UCLA Health, for an undisclosed amount.
Facilities
United States
As of 2024, HCA has 186 hospitals. They also report operating more than 2,400 additional sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics located in 20 U.S. states and in the United Kingdom. A significant portion of those hospitals are situated in Florida and Texas. As of 2022, HCA had 47 hospitals and 31 surgery centers in Florida, and 45 hospitals and 632 affiliated sites of care in Texas. In 2021, it announced plans to build 3 new hospitals in Florida. In 2022, The Dallas Morning News reported that HCA will build 5 new hospitals in Texas. They also have a strong presence in Tennessee, where it began. HCA had 13 hospitals there as of 2019.
Between 2003 and 2017, HCA did not enter any new markets. However, in July 2007, HCA sold its hospitals in Switzerland.
In 2017, HCA acquired the Memorial University Medical Center in Savannah, Georgia. That same year, they acquired three Houston, Texas, hospitals from Tenet Healthcare.
In 2019 they purchased Mission Health System which operates hospitals in North Carolina.
In January 2020, HCA Healthcare acquired Valify, a healthcare cost-management company. In May 2020, HCA acquired 49-bed Shands Starke (Fla.) Regional Medical Center and 25-bed Shands Live Oak (Fla.) Regional Medical Center from CHS. HCA is operating the two facilities as off-campus emergency departments of Lake City (Fla.) Medical Center and North Florida Regional Medical Center in Gainesville. Later that year, it signed an agreement to sell Garden Park Medical Center to Singing River Health System.
In 2021, HCA sold Redmond Regional Medical Center to AdventHealth for $635M, and four other Georgia hospitals to Piedmont Healthcare for $950 million. They also announced the acquisition of Meadows Regional Medical Center.
United Kingdom
HCA International, the UK arm of Hospital Corporation of America, "caters for around half of all private patients in London." The main hospital sites within the United Kingdom it operates include:
It opened urgent care walk-in centres at London Bridge Hospital and the Portland Hospital in March 2018. It claims that patients, on average, wait just seven minutes to see a nurse and 17 minutes to see a doctor. In February 2022, outsourced cleaning staff at London Bridge Hospital reported a lack of PPE, no access to sick pay, a lack of training and no prior warning about which rooms may be contaminated with the virus through the COVID-19 pandemic.
The Princess Grace Hospital specializes in breast cancer and surgery, aided by Kefah Mokbel and Nick Perry who, in 2005, founded The London Breast Institute.
The company opened The Harborne Hospital, a newly built private hospital located close to the Queen Elizabeth Hospital, Birmingham, in February 2024.
Significant areas of operation
Medical education
In recent years, HCA Healthcare has become a significant provider of clinical and medical education. It is the largest sponsor of graduate medical education programs in the U.S., with 56 teaching hospitals in 14 states, primarily in regions with a deficit of physician training programs. The company includes Research College of Nursing and Mercy School of Nursing, and has several advanced nursing simulation training centers. In early 2020, it completed the purchase of a majority stake in Galen College of Nursing, which operates 21 campuses in 12 states, offering Bachelor of Science and Associate of Science nursing degrees.
Controversies
Medicare billing practices lawsuit
In 1993, lawsuits were filed against HCA by former employees who alleged that the company had engaged in questionable Medicare billing practices. In 1997, with a federal investigation by the FBI, the IRS and the Department of Health and Human Services in its early stages, the Columbia/HCA board of directors forced Rick Scott to resign as chairman and CEO amid growing evidence that the company "had kept two sets of books, one to show the government and one with actual expenses listed." Thomas Frist, a co-founder of HCA and brother of U.S. Senator Bill Frist, returned to the company as CEO in 1997 and called on longtime friend and colleague Jack O. Bovender Jr. to help him turn the company around.
The federal probe culminated in 2003 with "the government receiving a total of over $2 billion in criminal fines and civil penalties for systematically defrauding federal health care programs." Columbia/HCA pleaded guilty to 14 felonies and admitted to systematically overcharging the government. The federal probe has been referred to as the longest and costliest investigation for health-care fraud in U.S. history.
2005 insider trading suit
In July 2005, U.S. Senator Bill Frist sold all of his HCA shares, which were held in a blind trust, two weeks before disappointing earnings sent the stock on a 9-point plunge. At the time, Frist was considering a run for president and said that he had sold his shares to avoid the appearance of a conflict of interest. When the company disclosed that other executives had also sold their shares during that same time, shareholders alleged that the company had made false claims about its profits to drive up the price, which then fell when the company reported disappointing financial results. Eleven of HCA's senior officers were sued for accounting fraud and insider trading. HCA settled the lawsuit in August 2007, agreeing to pay $20 million to the shareholders but admitting no wrongdoing, and no charges were brought.
COVID-19 PPE
During the COVID-19 pandemic in the United States, HCA hospital nurses and other workers spoke out about the lack of PPE. In April 2020, there was an outcry against HCA following the deaths of two nurses Celia Yap-Banago and Rosa Luna who worked at HCA hospitals in Kansas City and California and had contracted coronavirus, despite the alarm having been raised about the lack of PPE at work.
Mission Hospital Acquisition Complaints
On December 14, 2023, the North Carolina Attorney General sued HCA for violating the terms of an agreement that allowed HCA to purchase Mission Health.
On February 13, 2024, HCA Healthcare denied the allegations and asked a judge to dismiss the lawsuit by the Attorney General, and in return the hospital network filed a counterclaim against the Attorney General.
Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | HCA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | 14.3promedio 5A ≈13.8 | ≈13.8 | 16.5 | Infravalorado | |
| P/S (TTM) | 1.2promedio 5A ≈1.2 | ≈1.2 | 1.2 | Valor razonable | |
| P/C (MRQ) | -14.0promedio 5A ≈-39.2 | ≈-39.2 | · | · | |
| EV / EBITDA | 38.7promedio 5A ≈37.3 | ≈37.3 | 18.9 | Sobrevalorado | |
| Precio / FCF (TTM) | 15.5promedio 5A ≈14.6 | ≈14.6 | · | · | |
| Precio / Flujo de Caja (TTM) | 8.4promedio 5A ≈7.9 | ≈7.9 | 9.1 | Infravalorado | |
| EV / Revenue (EV / Ingresos) | 1.8promedio 5A ≈1.8 | ≈1.8 | · | · | |
| EV / FCF | 17.7promedio 5A ≈21.8 | ≈21.8 | · | · | |
| PEG Ratio (Ratio PEG) | ≈0.7 | · | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | HCA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| EBITDA Margin (Margen EBITDA) | 4.7%promedio 5A ≈4.8% | ≈4.8% | 11.1% | Débil | |
| Margen antes de impuestos (TTM) | 12.7%promedio 5A ≈13.6% | ≈13.6% | 10.3% | De primer nivel | |
| Margen de Beneficio Neto (TTM) | 8.8%promedio 5A ≈9.3% | ≈9.3% | 7.3% | En línea | |
| ROA (TTM) | 11.1%promedio 5A ≈11.2% | ≈11.2% | 6.5% | De primer nivel | |
| ROE (TTM) | -124.0%promedio 5A ≈-963.7% | ≈-963.7% | 19.1% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | HCA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Deuda / Patrimonio (MRQ) | -6.5promedio 5A ≈-19.5 | ≈-19.5 | 0.1 | Baja deuda | |
| Ratio corriente (MRQ) | 1.0promedio 5A ≈1.2 | ≈1.2 | 1.2 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 0.7promedio 5A ≈0.9 | ≈0.9 | 0.9 | Baja liquidez | |
| Deuda a Largo Plazo / Patrimonio (MRQ) | -6.5promedio 5A ≈-18.7 | ≈-18.7 | 0.1 | Baja deuda |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | HCA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 7.1%promedio 5A ≈8.0% | ≈8.0% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 7.9%promedio 5A ≈7.4% | ≈7.4% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 8.0% | · | · | · | |
| EPS YoY (EPS interanual) | 28.8%promedio 5A ≈25.6% | ≈25.6% | · | · | |
| Net Income YoY (Beneficio Neto interanual) | 17.8%promedio 5A ≈17.4% | ≈17.4% | · | · | |
| EPS CAGR 3Y (CAGR BPA 3A) | 13.9%promedio 5A ≈11.8% | ≈11.8% | · | · | |
| EPS CAGR 5Y (CAGR BPA 5A) | 21.0% | · | · | · | |
| Net Income CAGR 3Y (CAGR Beneficio Neto 3A) | 6.3%promedio 5A ≈4.0% | ≈4.0% | · | · | |
| Net Income CAGR 5Y (CAGR Beneficio Neto 5A) | 12.6% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | HCA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 1.3promedio 5A ≈1.2 | ≈1.2 | 0.8 | De primer nivel | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 7.0promedio 5A ≈7.1 | ≈7.1 | 8.3 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$328.7K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años
| Fecha ex-dividendo | Monto | Moneda | Rendimiento |
|---|---|---|---|
| Sep 16, 2026 | $0,78 | USD | ≈0.71% |
| Jun 16, 2026 | $0,78 | USD | ≈0.76% |
| Mar 17, 2026 | $0,78 | USD | ≈0.58% |
| Dic 15, 2025 | $0,72 | USD | ≈0.60% |
| Sep 16, 2025 | $0,72 | USD | ≈0.71% |
| Jun 16, 2025 | $0,72 | USD | ≈0.75% |
| Mar 17, 2025 | $0,72 | USD | ≈0.82% |
| Dic 13, 2024 | $0,66 | USD | ≈0.84% |
| Sep 16, 2024 | $0,66 | USD | ≈0.64% |
| Jun 14, 2024 | $0,66 | USD | ≈0.75% |
| Mar 14, 2024 | $0,66 | USD | ≈0.76% |
| Dic 13, 2023 | $0,60 | USD | ≈0.89% |
| Sep 14, 2023 | $0,60 | USD | ≈0.90% |
| Jun 15, 2023 | $0,60 | USD | ≈0.81% |
| Mar 16, 2023 | $0,60 | USD | ≈0.90% |
| Dic 13, 2022 | $0,56 | USD | ≈0.92% |
| Sep 15, 2022 | $0,56 | USD | ≈1.0% |
| Jun 15, 2022 | $0,56 | USD | ≈1.1% |
| Mar 16, 2022 | $0,56 | USD | ≈0.75% |
| Dic 13, 2021 | $0,48 | USD | ≈0.90% |
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Jul 23, 2026 | $7.62 | $7.54 | 1.0% |
| 31 de marzo de 2026 | $7.15 | $7.21 | -0.85% | |
| 31 de diciembre de 2025 | $8.14 | $7.53 | 8.0% | |
| 30 de septiembre de 2025 | $6.96 | $5.77 | 20.6% | |
| 30 de junio de 2025 | $6.83 | $6.31 | 8.2% | |
| 31 de marzo de 2025 | $6.45 | $5.84 | 10.5% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B | $51.53B | $51.34B | $46.68B | $43.61B | $41.49B | |
| SG&A Expense | $548M | $421M | $353M | $307M | $337M | $416M | $370M | $344M | $340M | $343M | |
| Operating Expenses | $65.77B | $62.08B | $57.26B | $51.65B | $48.92B | $46.10B | $46.09B | $41.34B | $39.23B | $36.68B | |
| Interest Expense | $2.25B | $2.06B | $1.94B | $1.74B | $1.57B | $1.58B | $1.82B | $1.75B | $1.69B | $1.71B | |
| Pretax Income | $9.83B | $8.52B | $7.71B | $8.58B | $9.83B | $5.43B | $5.24B | $5.33B | $4.38B | $4.81B | |
| Income Tax | $2.05B | $1.87B | $1.61B | $1.75B | $2.11B | $1.04B | $1.10B | $946M | $1.64B | $1.38B | |
| Net Income | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B | $3.75B | $3.50B | $3.79B | $2.22B | $2.89B | |
| EPS (Basic) | $28.70 | $22.27 | $19.25 | $19.43 | $21.52 | $11.10 | $10.27 | $10.90 | $6.12 | $7.53 | |
| EPS (Diluted) | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 | $10.93 | $10.07 | $10.66 | $5.95 | $7.30 | |
| Shares (Basic) | 236,413,000 | 258,603,000 | 272,404,000 | 290,348,000 | 323,315,000 | 338,274,000 | 341,210,000 | 347,297,000 | 362,305,000 | 383,591,000 | |
| Shares (Diluted) | 239,495,000 | 261,806,000 | 276,412,000 | 294,666,000 | 328,752,000 | 343,605,000 | 348,226,000 | 355,303,000 | 372,221,000 | 395,851,000 | |
| EBITDA | $3.52B | $3.31B | $3.08B | $2.97B | $2.85B | $2.72B | $2.60B | $2.28B | $2.13B | $1.97B |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.04B | $1.93B | $935M | $908M | $1.45B | $1.79B | $621M | $502M | $732M | $646M | |
| Short-term Investments | · | · | · | · | · | $116M | $147M | $47M | $54M | $49M | |
| Receivables | $10.87B | $10.75B | $9.96B | $8.89B | $8.10B | $7.05B | $7.38B | $6.79B | $6.50B | $5.83B | |
| Inventory | $1.65B | $1.74B | $2.02B | $2.07B | $1.99B | $2.02B | $1.85B | $1.73B | $1.57B | $1.50B | |
| Other Current Assets | $2.22B | $1.99B | $2.01B | $1.78B | $2.01B | $1.46B | $1.35B | $1.19B | $1.17B | $1.11B | |
| Current Assets | $15.78B | $16.41B | $14.93B | $13.64B | $13.54B | $12.33B | $11.20B | $10.21B | $9.98B | $9.09B | |
| PP&E (Net) | $31.14B | $29.41B | $27.71B | $25.57B | $24.06B | $23.20B | $22.71B | $19.76B | $17.89B | $16.35B | |
| PP&E (Gross) | $66.28B | $62.51B | $58.55B | $54.76B | $51.35B | $49.32B | $47.23B | $42.97B | $40.08B | $37.05B | |
| Accum. Depreciation | $35.13B | $33.10B | $30.83B | $29.18B | $27.29B | $26.12B | $24.52B | $23.21B | $22.19B | $20.70B | |
| Other Non-current Assets | $255M | $230M | $184M | $298M | $598M | $546M | $480M | $690M | $710M | $1.07B | |
| Total Assets | $60.72B | $59.51B | $56.21B | $52.44B | $50.74B | $47.49B | $45.06B | $39.21B | $36.59B | $33.76B | |
| Accounts Payable | $4.66B | $4.28B | $4.23B | $4.24B | $4.11B | $3.54B | $2.90B | $2.58B | $2.61B | $2.32B | |
| Current Liabilities | $16.35B | $15.18B | $12.65B | $9.90B | $9.58B | $8.70B | $7.76B | $7.57B | $6.16B | $5.83B | |
| Capital Leases | $1.85B | $1.86B | $1.90B | $1.75B | $1.75B | $1.67B | $1.50B | · | · | · | |
| Total Liabilities | · | · | · | · | · | · | $45.62B | $42.12B | $41.59B | $39.39B | |
| Long-term Debt | $44.28B | $43.03B | $39.59B | $38.08B | $34.58B | $31.00B | $33.72B | $32.82B | $33.06B | $31.38B | |
| Total Debt | $41.60B | $43.03B | $39.59B | $38.08B | $34.58B | $31.00B | $33.72B | $32.82B | $33.06B | $31.38B | |
| Retained Earnings | $-5.72B | $-2.12B | $-1.35B | $-2.28B | $-532M | $777M | $-2.35B | $-4.57B | $-6.53B | $-6.97B | |
| AOCI | $-305M | $-387M | $-425M | $-490M | $-404M | $-502M | $-460M | $-381M | $-278M | $-338M | |
| Stockholders' Equity | $-6.03B | $-2.50B | $-1.77B | $-2.77B | $-933M | $572M | $-2.81B | $-4.95B | $-6.81B | $-7.30B | |
| Liabilities + Equity | $60.72B | $59.51B | $56.21B | $52.44B | $50.74B | $47.49B | $45.06B | $39.21B | $36.59B | $33.76B | |
| Shares Outstanding | 224,605,100 | 249,981,400 | 265,537,300 | 277,378,300 | 305,476,800 | 339,425,600 | 338,445,600 | 342,895,200 | 350,091,600 | 370,535,900 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3.52B | $3.31B | $3.08B | $2.97B | $2.85B | $2.72B | $2.60B | $2.28B | $2.13B | $1.97B | |
| Stock-based Comp | $401M | $360M | $262M | $341M | $440M | $362M | $347M | $268M | $270M | $251M | |
| Amort. of Intangibles | $12M | $16M | $20M | $44M | $25M | $26M | · | · | · | · | |
| Other Non-cash | $1.93B | $1.08B | $850M | $-431M | $-1.29B | $2.40B | $1.07B | $461M | $-3.53B | $-2.67B | |
| Operating Cash Flow | $12.64B | $10.51B | $9.43B | $8.52B | $8.96B | $9.23B | $7.60B | $6.76B | $5.43B | $5.65B | |
| CapEx | $4.94B | $4.88B | $4.74B | $4.39B | $3.58B | $2.83B | $4.16B | $3.57B | $3.02B | $2.76B | |
| Investing Cash Flow | $-4.99B | $-4.93B | $-5.32B | $-3.39B | $-2.64B | $-3.39B | $-5.72B | $-3.90B | $-4.28B | $-3.24B | |
| Debt Issued | $8.47B | $7.50B | $3.22B | $6.00B | $4.34B | $2.70B | $6.45B | $2.00B | $1.50B | $5.40B | |
| Net Debt Issued | $1.08B | $5.08B | $2.31B | $3.17B | $475M | $-737M | $1.13B | $296M | $749M | $925M | |
| Stock Repurchased | $10.07B | $6.04B | $3.81B | $7.00B | $8.21B | $441M | $1.03B | $1.53B | $2.05B | $2.75B | |
| Net Stock Activity | $-10.07B | $-6.04B | $-3.81B | $-7.00B | $-8.21B | $-441M | $-1.03B | $-1.53B | $-2.05B | $-2.75B | |
| Dividends Paid | $679M | $690M | $661M | $653M | $624M | $153M | $550M | $487M | $0 | · | |
| Financing Cash Flow | $-8.55B | $-4.58B | $-4.09B | $-5.66B | $-6.66B | $-4.68B | $-1.77B | $-3.08B | $-1.06B | $-2.51B | |
| Net Change in Cash | $-893M | $998M | $27M | $-543M | $-342M | $1.17B | $119M | $-230M | $86M | $-95M | |
| Taxes Paid | $1.74B | $1.84B | $1.39B | $1.18B | $2.18B | $1.00B | $849M | $872M | $1.21B | $1.25B | |
| Free Cash Flow | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B | $6.40B | $3.44B | $3.19B | $2.41B | $2.89B | |
| Levered FCF | $5.91B | $4.03B | $3.16B | $2.74B | $4.15B | $5.12B | $2.00B | $1.74B | $1.35B | $1.68B |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 9.0% | 8.2% | 8.1% | 9.4% | 11.8% | 7.3% | 6.8% | 8.1% | · | · | |
| Pretax Margin | 13.0% | 12.1% | 11.9% | 14.2% | 16.7% | 10.5% | 10.2% | 11.4% | · | · | |
| EBITDA Margin | 4.7% | 4.7% | 4.7% | 4.9% | 4.9% | 5.3% | 5.1% | 4.9% | · | · | |
| ROA | 11.3% | 10.0% | 9.7% | 10.9% | 14.2% | 8.1% | 8.3% | 10.0% | 6.3% | 8.7% | |
| ROE | -159.1% | -269.6% | -230.9% | -305.0% | -3853.7% | -335.8% | -90.4% | -64.4% | -31.4% | -38.8% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 1.1 | 1.2 | 1.4 | 1.4 | 1.4 | 1.4 | 1.3 | 1.6 | 1.6 | |
| Quick Ratio | 0.7 | 0.8 | 0.9 | 1.0 | 1.0 | 1.0 | 1.1 | 1.0 | 1.2 | 1.1 | |
| Debt / Equity | -6.9 | -17.2 | -22.3 | -13.8 | -37.1 | 54.2 | -12.0 | -6.6 | -4.9 | -4.3 | |
| LT Debt / Equity | -6.9 | -15.3 | -21.0 | -13.6 | -36.8 | 53.8 | -12.0 | -6.5 | -4.8 | -4.3 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.3 | 1.2 | 1.2 | 1.2 | 1.2 | 1.1 | 1.2 | 1.2 | · | · | |
| Receivables Turnover | 7.0 | 6.8 | 6.9 | 7.1 | 7.8 | 7.1 | 7.2 | 7.0 | · | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-26.83 | $-10.00 | $-6.68 | $-9.98 | $-3.05 | $1.69 | $-8.30 | $-14.44 | $-19.44 | $-19.71 | |
| Revenue / Share | $315.66 | $269.68 | $235.04 | $204.41 | $178.71 | $149.98 | $147.42 | $131.37 | · | · | |
| Cash Flow / Share | $52.76 | $40.16 | $34.12 | $28.92 | $27.25 | $26.87 | $21.83 | $19.03 | $14.58 | $14.28 | |
| Cash / Share | $4.63 | $7.73 | $3.52 | $3.27 | $4.75 | $5.28 | $1.83 | $1.46 | $2.09 | $1.74 | |
| Dividend / Share | $2.88 | $2.64 | $2.40 | $2.24 | $1.92 | $0.43 | $1.60 | $1.40 | · | · | |
| EPS (TTM) | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 | $10.93 | $10.07 | $10.66 | $5.95 | $7.30 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.1% | 8.7% | 7.9% | 2.5% | 14.0% | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.9% | 6.3% | 8.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.0% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 28.8% | 16.0% | -0.94% | -9.5% | 93.6% | · | · | · | · | · | |
| EPS CAGR 3Y | 13.9% | 1.3% | 20.2% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 21.0% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 17.8% | 9.9% | -7.1% | -18.9% | 85.3% | · | · | · | · | · | |
| Net Income CAGR 3Y | 6.3% | -6.1% | 11.8% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 12.6% | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 34.7% | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B | $51.53B | $51.34B | $46.68B | $43.61B | $41.49B | |
| Net Income TTM | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B | $3.75B | $3.50B | $3.79B | $2.22B | $2.89B | |
| Market Cap | $104.86B | $75.03B | $71.88B | $66.56B | $78.48B | $55.82B | $50.03B | $42.67B | $30.75B | $27.43B | |
| Enterprise Value | $145.42B | $116.13B | $110.53B | $103.74B | $111.61B | $84.92B | $82.98B | $74.95B | $63.02B | $58.11B | |
| P/E | 16.5 | 13.6 | 14.3 | 12.5 | 12.1 | 15.0 | 14.7 | 11.7 | 14.8 | 10.1 | |
| P/S | 1.4 | 1.1 | 1.1 | 1.1 | 1.3 | 1.1 | 1.0 | 0.9 | 0.7 | 0.7 | |
| P/B | -17.4 | -30.0 | -40.5 | -24.1 | -84.1 | 97.6 | -17.8 | -8.6 | -4.5 | -3.8 | |
| P / Tangible Book | · | · | · | · | · | 97.6 | · | · | · | · | |
| P / Cash Flow | 8.3 | 7.1 | 7.6 | 7.8 | 8.8 | 6.0 | 6.6 | 6.3 | 5.7 | 4.9 | |
| P / FCF | 13.6 | 13.3 | 15.3 | 16.1 | 14.6 | 8.7 | 14.5 | 13.4 | 12.8 | 9.5 | |
| EV / EBITDA | 41.3 | 35.1 | 35.9 | 34.9 | 39.1 | 31.2 | 32.0 | 32.9 | 29.6 | 29.6 | |
| EV / FCF | 18.9 | 20.6 | 23.6 | 25.1 | 20.7 | 13.3 | 24.1 | 23.5 | 26.1 | 20.1 | |
| EV / Revenue | 1.9 | 1.6 | 1.7 | 1.7 | 1.9 | 1.6 | 1.6 | 1.6 | 1.4 | 1.4 | |
| Dividend Yield | 0.65% | 0.92% | 0.92% | 0.98% | 0.80% | 0.27% | 1.1% | 1.1% | 0.00% | · | |
| Earnings Yield | 6.1% | 7.3% | 7.0% | 8.0% | 8.2% | 6.7% | 6.8% | 8.6% | 6.8% | 9.9% | |
| Payout Ratio | 10.0% | 12.0% | 12.6% | 11.6% | 9.0% | 4.1% | 15.7% | 12.9% | · | · | |
| Annual Payout | $679M | $690M | $661M | $653M | $624M | $153M | $550M | $487M | $0 | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.23B | $19.11B | $19.51B | $19.16B | $18.61B | $18.32B | $18.29B | $17.49B | $17.49B | $17.34B | $17.30B | $16.21B | $15.86B | $15.59B | $15.50B | $14.97B | |
| SG&A Expense | $148M | $133M | $153M | $139M | $130M | $126M | $120M | $111M | $100M | $90M | $108M | $89M | $82M | $74M | $79M | $74M | |
| Operating Expenses | $17.74B | $16.82B | $16.84B | $16.74B | $16.19B | $15.99B | $16.15B | $15.58B | $15.26B | $15.09B | $14.96B | $14.58B | $14.05B | $13.67B | $12.20B | $13.27B | |
| Interest Expense | $599M | $584M | $572M | $561M | $568M | $547M | $528M | $515M | $506M | $512M | $491M | $483M | $485M | $479M | $453M | $446M | |
| Pretax Income | $2.49B | $2.29B | $2.67B | $2.42B | $2.42B | $2.33B | $2.13B | $1.91B | $2.24B | $2.25B | $2.35B | $1.63B | $1.81B | $1.92B | $3.30B | $1.70B | |
| Income Tax | $564M | $430M | $509M | $515M | $524M | $502M | $447M | $424M | $550M | $445M | $484M | $355M | $397M | $379M | $656M | $360M | |
| Net Income | $1.70B | $1.62B | $1.88B | $1.64B | $1.65B | $1.61B | $1.44B | $1.27B | $1.46B | $1.59B | $1.61B | $1.08B | $1.19B | $1.36B | $2.08B | $1.13B | |
| EPS (Basic) | $7.70 | $7.25 | $8.22 | $7.05 | $6.91 | $6.52 | $5.72 | $4.94 | $5.60 | $6.01 | $6.00 | $3.98 | $4.35 | $4.92 | $7.30 | $3.97 | |
| EPS (Diluted) | $7.62 | $7.15 | $8.09 | $6.96 | $6.83 | $6.45 | $5.66 | $4.88 | $5.53 | $5.93 | $5.92 | $3.91 | $4.29 | $4.85 | $7.20 | $3.91 | |
| Shares (Basic) | 220,538,000 | 223,588,000 | · | 232,891,000 | 239,173,000 | 246,936,000 | · | 256,763,000 | 261,156,000 | 264,435,000 | · | 271,173,000 | 274,494,000 | 276,910,000 | · | 285,958,000 | |
| Shares (Diluted) | 222,828,000 | 226,652,000 | · | 236,181,000 | 241,911,000 | 249,440,000 | · | 259,917,000 | 264,071,000 | 268,016,000 | · | 275,424,000 | 278,198,000 | 280,961,000 | · | 289,852,000 | |
| EBITDA | $944M | $930M | · | $889M | $863M | $860M | · | $842M | $819M | $795M | · | $769M | $763M | $756M | · | $749M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.01B | $940M | $1.04B | $997M | $939M | $1.06B | $1.93B | $2.89B | $831M | $1.28B | · | $891M | $862M | $842M | · | $999M | |
| Receivables | $12.28B | $11.32B | $10.87B | $10.43B | $10.46B | $11.09B | $10.75B | $9.91B | $10.24B | $10.04B | · | $9.18B | $8.71B | $8.66B | · | $8.55B | |
| Inventory | $1.66B | $1.68B | $1.65B | $1.73B | $1.79B | $1.79B | $1.74B | $1.78B | $1.80B | $1.90B | · | $2.03B | $2.05B | $2.08B | · | $2.01B | |
| Other Current Assets | $2.23B | $2.11B | $2.22B | $2.13B | $2.37B | $2.32B | $1.99B | $2.08B | $2.30B | $2.05B | · | $2.19B | $2.26B | $1.96B | · | $1.92B | |
| Current Assets | $17.19B | $16.05B | $15.78B | $15.29B | $15.56B | $16.26B | $16.41B | $16.66B | $15.17B | $15.28B | · | $14.29B | $13.89B | $13.54B | · | $13.48B | |
| PP&E (Net) | $31.82B | $31.47B | $31.14B | $30.57B | $30.12B | $29.74B | $29.41B | $29.05B | $28.64B | $28.10B | · | $27.12B | $26.64B | $26.05B | · | $24.98B | |
| PP&E (Gross) | $68.41B | $67.36B | $66.28B | $65.49B | $64.39B | $63.68B | $62.51B | $61.75B | $60.62B | $59.44B | · | $57.77B | $56.67B | $55.46B | · | $53.73B | |
| Accum. Depreciation | $36.59B | $35.89B | $35.13B | $34.92B | $34.27B | $33.94B | $33.10B | $32.70B | $31.99B | $31.34B | · | $30.66B | $30.02B | $29.41B | · | $28.75B | |
| Other Non-current Assets | $258M | $326M | $255M | $277M | $236M | $226M | $230M | $309M | $240M | $199M | · | $200M | $196M | $319M | · | $461M | |
| Total Assets | $63.25B | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B | $59.51B | $59.46B | $57.38B | $56.96B | $56.21B | $54.59B | $53.59B | $52.71B | $52.44B | $51.48B | |
| Accounts Payable | $4.75B | $4.81B | $4.66B | $4.55B | $4.25B | $4.49B | $4.28B | $4.24B | $4.03B | $4.74B | · | $4.14B | $3.82B | $3.77B | · | $4.16B | |
| Current Liabilities | $17.31B | $19.26B | $16.35B | $17.90B | $15.94B | $13.63B | $15.18B | $14.90B | $14.30B | $13.14B | · | $12.41B | $11.54B | $11.03B | · | $9.78B | |
| Capital Leases | $1.83B | $1.82B | $1.85B | $1.84B | $1.88B | $1.86B | $1.86B | $1.92B | $1.89B | $1.91B | · | $1.78B | $1.81B | $1.72B | · | $1.76B | |
| Long-term Debt | $45.83B | $44.37B | $44.28B | $42.60B | $42.70B | $44.58B | $43.03B | $42.97B | $40.88B | $40.19B | · | $39.35B | $38.93B | $38.86B | · | $37.71B | |
| Total Debt | $43.45B | $39.49B | · | $38.40B | $39.38B | $44.58B | · | $42.97B | $40.88B | $40.19B | · | $39.35B | $38.93B | $38.86B | · | $37.71B | |
| Retained Earnings | $-6.31B | $-5.98B | $-5.72B | $-5.02B | $-4.09B | $-3.16B | $-2.12B | $-1.81B | $-1.17B | $-1.19B | · | $-1.99B | $-1.85B | $-2.03B | · | $-2.78B | |
| AOCI | $-334M | $-327M | $-305M | $-317M | $-309M | $-357M | $-387M | $-378M | $-433M | $-433M | $-425M | $-491M | $-456M | $-470M | $-490M | $-592M | |
| Stockholders' Equity | $-6.64B | $-6.30B | $-6.03B | $-5.33B | $-4.39B | $-3.52B | $-2.50B | $-2.18B | $-1.60B | $-1.61B | · | $-2.48B | $-2.30B | $-2.50B | · | $-3.37B | |
| Liabilities + Equity | $63.25B | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B | $59.51B | $59.46B | $57.38B | $56.96B | · | $54.59B | $53.59B | $52.71B | · | $51.48B | |
| Shares Outstanding | 217,963,300 | 222,530,900 | 224,605,100 | 229,845,100 | 236,143,900 | 242,955,400 | 249,981,400 | 254,517,700 | 259,237,600 | 263,215,800 | · | 268,967,300 | 272,931,700 | 275,939,900 | · | 283,903,500 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $944M | $930M | $911M | $889M | $863M | $860M | $856M | $842M | $819M | $795M | $789M | $769M | $763M | $756M | $750M | $749M | |
| Stock-based Comp | $85M | $86M | $100M | $104M | $99M | $98M | $85M | $76M | $112M | $87M | $57M | $72M | $56M | $77M | $83M | $87M | |
| Other Non-cash | · | $-622M | · | · | · | $-917M | · | · | · | $-4M | · | · | · | $-393M | · | · | |
| Operating Cash Flow | $2.33B | $2.01B | $2.36B | $4.42B | $4.21B | $1.65B | $2.56B | $3.52B | $1.97B | $2.47B | $2.67B | $2.48B | $2.48B | $1.80B | $2.53B | $3.02B | |
| CapEx | $1.23B | $1.12B | $1.49B | $1.29B | $1.18B | $991M | $1.28B | $1.19B | $1.28B | $1.12B | $1.16B | $1.15B | $1.24B | $1.20B | $1.32B | $1.13B | |
| Investing Cash Flow | $-1.56B | $-1.28B | $-1.32B | $-1.39B | $-1.25B | $-1.03B | $-1.35B | $-1.35B | $-1.33B | $-903M | $-1.60B | $-1.31B | $-1.26B | $-1.15B | $-793M | $-546M | |
| Debt Issued | $2.99B | $0 | $3.24B | $0 | $0 | $5.23B | $0 | $3.01B | $0 | $4.48B | $4M | $2M | $3.22B | $0 | $21M | $10M | |
| Net Debt Issued | · | $-58M | · | · | · | $1.34B | · | · | · | $2.42B | · | · | · | $-550M | · | · | |
| Stock Repurchased | $2.06B | $1.57B | $2.56B | $2.50B | $2.50B | $2.51B | $1.70B | $1.79B | $1.37B | $1.18B | $910M | $1.14B | $915M | $846M | $1.52B | $698M | |
| Net Stock Activity | · | $-1.57B | · | · | · | $-2.51B | · | · | · | $-1.18B | · | · | · | $-846M | · | · | |
| Dividends Paid | $171M | $183M | $162M | $166M | $171M | $180M | $165M | $169M | $171M | $185M | $160M | $162M | $164M | $175M | $156M | $160M | |
| Financing Cash Flow | $-704M | $-830M | $-999M | $-2.97B | $-3.09B | $-1.50B | $-2.16B | $-110M | $-1.09B | $-1.22B | $-1.04B | $-1.13B | $-1.20B | $-725M | $-1.84B | $-2.32B | |
| Net Change in Cash | $73M | $-100M | $43M | $58M | $-121M | $-873M | $-955M | $2.06B | $-453M | $349M | $44M | $29M | $20M | $-66M | $-91M | $141M | |
| Taxes Paid | $730M | $-5M | $1.51B | $81M | $136M | $10M | $358M | $487M | $998M | $1M | $316M | $297M | $766M | $7M | $244M | $322M | |
| Free Cash Flow | · | $895M | · | · | · | $660M | · | · | · | $1.35B | · | · | · | $606M | · | · | |
| Levered FCF | · | $421M | · | · | · | $231M | · | · | · | $940M | · | · | · | $221M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 8.4% | 8.5% | · | 8.6% | 8.9% | 8.8% | · | 7.3% | 8.3% | 9.2% | · | 6.7% | 7.5% | 8.7% | · | 7.6% | |
| Pretax Margin | 12.3% | 12.0% | · | 12.6% | 13.0% | 12.7% | · | 10.9% | 12.8% | 13.0% | · | 10.1% | 11.4% | 12.3% | · | 11.4% | |
| EBITDA Margin | 4.7% | 4.9% | · | 4.6% | 4.6% | 4.7% | · | 4.8% | 4.7% | 4.6% | · | 4.7% | 4.8% | 4.9% | · | 5.0% | |
| ROA | 2.8% | 2.7% | · | 2.8% | 2.8% | 2.8% | · | 2.2% | 2.6% | 2.9% | · | 2.0% | 2.3% | 2.6% | · | 2.2% | |
| ROE | -30.8% | -33.0% | · | -43.7% | -55.2% | -62.7% | · | -54.5% | -74.9% | -77.4% | · | -36.9% | -39.9% | -60.2% | · | -55.8% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 0.8 | · | 0.9 | 1.0 | 1.2 | · | 1.1 | 1.1 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.4 | |
| Quick Ratio | 0.8 | 0.6 | · | 0.6 | 0.7 | 0.9 | · | 0.9 | 0.8 | 0.9 | · | 0.8 | 0.8 | 0.9 | · | 1.0 | |
| Debt / Equity | -6.5 | -6.3 | · | -7.2 | -9.0 | -12.7 | · | -19.7 | -25.6 | -24.9 | · | -15.9 | -16.9 | -15.6 | · | -11.2 | |
| LT Debt / Equity | -6.5 | -6.3 | · | -7.2 | -9.0 | -11.7 | · | -17.5 | -22.7 | -23.0 | · | -14.9 | -15.9 | -14.6 | · | -11.1 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.8 | 1.7 | · | 1.9 | 1.8 | 1.7 | · | 1.8 | 1.8 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 1.8 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-30.47 | $-28.32 | · | $-23.21 | $-18.61 | $-14.48 | · | $-8.57 | $-6.17 | $-6.14 | · | $-9.21 | $-8.44 | $-9.04 | · | $-11.87 | |
| Revenue / Share | $90.79 | $84.31 | · | $81.13 | $76.91 | $73.45 | · | $67.28 | $66.24 | $64.69 | · | $58.87 | $57.01 | $55.49 | · | $51.65 | |
| Cash Flow / Share | · | $8.89 | · | · | · | $6.62 | · | · | · | $9.21 | · | · | · | $6.42 | · | · | |
| Cash / Share | $4.65 | $4.22 | · | $4.34 | $3.98 | $4.36 | · | $11.35 | $3.21 | $4.88 | · | $3.31 | $3.16 | $3.05 | · | $3.52 | |
| Dividend / Share | $0.78 | $0.78 | $0.72 | $0.72 | $0.72 | $0.72 | $0.66 | $0.66 | $0.66 | $0.66 | $0.60 | $0.60 | $0.60 | $0.60 | $0.56 | $0.56 | |
| EPS (TTM) | $29.82 | $29.03 | · | $25.90 | $23.82 | $22.52 | · | $22.26 | $21.29 | $20.05 | · | $20.25 | $20.25 | $19.86 | · | $17.61 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $78.01B | $76.39B | · | $74.37B | $72.70B | $71.58B | · | $69.62B | $68.35B | $66.72B | · | $63.16B | $61.92B | $60.88B | · | $59.80B | |
| Net Income TTM | $6.84B | $6.79B | · | $6.34B | $5.97B | $5.78B | · | $5.93B | $5.74B | $5.47B | · | $5.72B | $5.77B | $5.73B | · | $5.38B | |
| Market Cap | $84.98B | $105.31B | · | $97.96B | $90.47B | $83.95B | · | $103.44B | $83.29B | $87.79B | · | $66.16B | $82.83B | $72.76B | · | $52.18B | |
| Enterprise Value | $127.42B | $143.86B | · | $135.36B | $128.91B | $127.47B | · | $143.52B | $123.34B | $126.70B | · | $104.62B | $120.90B | $110.77B | · | $88.89B | |
| P/E | 13.1 | 16.3 | · | 16.5 | 16.1 | 15.3 | · | 18.3 | 15.1 | 16.6 | · | 12.1 | 15.0 | 13.3 | · | 10.4 | |
| P/S | 1.1 | 1.4 | · | 1.3 | 1.2 | 1.2 | · | 1.5 | 1.2 | 1.3 | · | 1.0 | 1.3 | 1.2 | · | 0.9 | |
| P/B | -12.8 | -16.7 | · | -18.4 | -20.6 | -23.9 | · | -47.4 | -52.1 | -54.4 | · | -26.7 | -36.0 | -29.2 | · | -15.5 | |
| P / Cash Flow | · | 52.3 | · | · | · | 50.8 | · | · | · | 35.6 | · | · | · | 40.4 | · | · | |
| EV / Revenue | 1.6 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 2.1 | 1.8 | 1.9 | · | 1.7 | 2.0 | 1.8 | · | 1.5 | |
| Dividend Yield | 0.80% | 0.65% | · | 0.70% | 0.76% | 0.82% | · | 0.66% | 0.81% | 0.76% | · | 0.99% | 0.79% | 0.89% | · | 1.2% | |
| Earnings Yield | 7.6% | 6.1% | · | 6.1% | 6.2% | 6.5% | · | 5.5% | 6.6% | 6.0% | · | 8.2% | 6.7% | 7.5% | · | 9.6% | |
| Payout Ratio | · | 11.3% | · | · | · | 11.2% | · | · | · | 11.6% | · | · | · | 12.8% | · | · | |
| Annual Payout | $682M | $682M | · | $682M | $685M | $685M | · | $685M | $678M | $671M | · | $657M | $655M | $651M | · | $645M |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B |
| Beneficio neto | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B |
| EPS Diluido | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | -6.9 | -17.2 | -22.3 | -13.8 | -37.1 |
| Ratio corriente | 1.0 | 1.1 | 1.2 | 1.4 | 1.4 |
| Ratio Rápido | 0.7 | 0.8 | 0.9 | 1.0 | 1.0 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B |
Propietarios institucionales (13F) 1 473 declarantes · $57.3B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 121 (-64 vs trimestre anterior) | 176 (+72 vs trimestre anterior) | 458 (-25 vs trimestre anterior) | 581 (+4 vs trimestre anterior) | -627K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $6 870 392 526 | 14 716 173 | 12,00% | Acciones |
| BlackRock, Inc. | $5 069 973 824 | 13 003 600 | 8,85% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $3 954 150 533 | 10 141 708 | 6,91% | Acciones |
| Sanders Capital, LLC | $3 442 060 818 | 8 828 287 | 6,01% | Acciones |
| STATE STREET CORP | $2 912 102 056 | 7 469 035 | 5,09% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $1 835 396 649 | 4 707 473 | 3,21% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $1 423 654 808 | 3 668 008 | 2,49% | Acciones |
| First Eagle Investment Management, LLC | $1 284 907 912 | 3 295 565 | 2,24% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 057 704 509 | 2 712 828 | 1,85% | Acciones |
| MORGAN STANLEY | $1 008 556 857 | 2 586 771 | 1,76% | Acciones |
| GOLDMAN SACHS GROUP INC | $960 811 481 | 2 464 314 | 1,68% | Acciones |
| JPMORGAN CHASE & CO | $896 800 955 | 2 285 832 | 1,57% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $861 456 107 | 2 209 485 | 1,50% | Acciones |
| NORGES BANK | $836 457 140 | 2 145 367 | 1,46% | Acciones |
| Capital World Investors | $770 864 224 | 1 977 121 | 1,35% | Acciones |
| Capital International Investors | $747 403 041 | 1 916 947 | 1,31% | Acciones |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $709 859 997 | 1 500 000 | 1,24% | Acciones |
| NORTHERN TRUST CORP | $666 150 458 | 1 708 560 | 1,16% | Acciones |
| FMR LLC | $636 503 475 | 1 632 520 | 1,11% | Acciones |
| Invesco Ltd. | $596 390 232 | 1 529 637 | 1,04% | Acciones |
| NORDEA INVESTMENT MANAGEMENT AB | $553 702 529 | 1 429 943 | 0,97% | Acciones |
| BARCLAYS PLC | $514 349 127 | 1 319 216 | 0,90% | Acciones |
| JANUS HENDERSON GROUP PLC | $481 486 890 | 1 017 441 | 0,84% | Acciones |
| Crake Asset Management LLP | $449 072 183 | 1 151 792 | 0,78% | Acciones |
| Metropolis Capital Ltd | $430 915 307 | 910 564 | 0,75% | Acciones |
| Darsana Capital Partners LP | $428 879 000 | 1 100 000 | 0,75% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $414 565 358 | 1 063 288 | 0,72% | Acciones |
| Legal & General Group Plc | $410 992 402 | 1 054 124 | 0,72% | Acciones |
| FRANKLIN RESOURCES INC | $399 958 688 | 1 025 824 | 0,70% | Acciones |
| Life Cycle Investment Partners Ltd | $355 737 196 | 912 404 | 0,62% | Acciones |
| Bank of New York Mellon Corp | $350 359 895 | 898 612 | 0,61% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $339 685 814 | 871 235 | 0,59% | Acciones |
| ROYAL BANK OF CANADA | $320 194 000 | 821 241 | 0,56% | Acciones |
| LYRICAL ASSET MANAGEMENT LP | $255 015 742 | 654 071 | 0,45% | Acciones |
| BANK OF AMERICA CORP /DE/ | $238 456 934 | 611 601 | 0,42% | Acciones |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $237 236 367 | 608 470 | 0,41% | Acciones |
| ROYAL LONDON ASSET MANAGEMENT LTD | $235 649 908 | 604 401 | 0,41% | Acciones |
| PRINCIPAL FINANCIAL GROUP INC | $234 827 401 | 602 290 | 0,41% | Acciones |
| UBS Group AG | $230 953 291 | 592 355 | 0,40% | Acciones |
| National Pension Service | $230 650 346 | 591 578 | 0,40% | Acciones |
| Russell Investments Group, Ltd. | $206 832 565 | 530 340 | 0,36% | Acciones |
| Nuveen, LLC | $199 595 109 | 511 927 | 0,35% | Acciones |
| Gobi Capital LLC | $195 742 325 | 502 045 | 0,34% | Acciones |
| Cryder Capital Partners LLP | $194 561 738 | 499 017 | 0,34% | Acciones |
| Allianz Asset Management GmbH | $181 127 299 | 464 560 | 0,32% | Acciones |
| DEUTSCHE BANK AG\ | $175 985 429 | 451 372 | 0,31% | Acciones |
| Swiss National Bank | $172 097 446 | 441 400 | 0,30% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $172 079 393 | 441 313 | 0,30% | Acciones |
| AustralianSuper Pty Ltd | $159 635 782 | 409 438 | 0,28% | Acciones |
| HSBC HOLDINGS PLC | $158 555 065 | 406 750 | 0,28% | Acciones |
Activistas y propietarios del %+ 5 4 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan | 10 de febrero de 2026 | 31,60% | Presentación inicial | · | SEC |
| 22 de noviembre de 2006 | · | Presentación inicial | · | SEC | |
| Merrill Lynch Bank USA | 11 de septiembre de 2006 | · | Presentación inicial | · | SEC |
| Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC | 4 de agosto de 2006 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 92 insiders · 54 directivos · 31 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Samuel N Hazen | CEO | 10 de febrero de 2026 F | 64 842 | 0 | 7 | $-21 483 290 |
| O'Boyle Michael P | President & CEO - Parallon | 26 de febrero de 2013 A | 21 429 | 0 | 0 | $0 |
| Mike A Marks | EVP and CFO | 7 de mayo de 2026 G | 46 576 | 0 | 0 | $0 |
| Bill B Rutherford | CFO and EVP | 16 de febrero de 2024 F | 22 251 | 0 | 0 | $0 |
| Russell K Harms | CFO - Central Group | 17 de noviembre de 2006 D | 0 | 0 | 0 | $0 |
| Robert Samuel Hankins JR | CFO-Outpatient Services Group | 17 de noviembre de 2006 D | 0 | 0 | 0 | $0 |
| Richard J Shallcross | CFO - Western Group | 17 de noviembre de 2006 D | 0 | 0 | 0 | $0 |
| Jeffrey T Crudele | CFO-Eastern Division | 1 de julio de 2005 F | 13 865 | 0 | 0 | $0 |
| Erol R Akdamar | Group President | 12 de noviembre de 2024 M | 6 843 | 0 | 0 | $0 |
| Timothy M Mcmanus | Group President | 31 de julio de 2024 M | 27 008 | 0 | 0 | $0 |
| Richard A Hammett | Group President | 16 de febrero de 2024 F | 17 936 | 0 | 0 | $0 |
| Charles J Hall | Group President | 11 de noviembre de 2022 M | 202 443 | 0 | 0 | $0 |
| Bruce A Moore JR | Group President - Service Line | 11 de noviembre de 2022 S | 30 807 | 0 | 0 | $0 |
| Paul W Rutledge | Group President | 31 de diciembre de 2012 A | 335 657 | 0 | 0 | $0 |
| Beverly B Wallace | President - Parallon | 2 de noviembre de 2011 M | 144 714 | 0 | 0 | $0 |
| Charles Robert Evans | President - Eastern Group | 26 de julio de 2006 A | 62 173 | 0 | 0 | $0 |
| Marilyn B Tavenner | President-Outpatient Svcs Grp | 27 de octubre de 2005 A | 26 154 | 0 | 0 | $0 |
| Greg Roth | President-Ambulatory Surgery | 31 de octubre de 2004 D | 9 029 | 0 | 0 | $0 |
| Jay Grinney | President-Eastern Group | 7 de mayo de 2004 D | 24 177 | 0 | 0 | $0 |
| Jon M Foster | EVP and COO | 10 de febrero de 2026 F | 23 062 | 0 | 0 | $0 |
| Michael R Mcalevey | EVP & Chief Legal & Admin Off. | 26 de agosto de 2026 J | 0 | 0 | 2 | $-2 747 520 |
| Jennifer Berres | SVP & Chief Human Res. Officer | 11 de febrero de 2026 S | 11 993 | 0 | 2 | $-4 126 932 |
| Christopher F. Wyatt | SVP & Controller | 11 de febrero de 2026 S | 44 379 | 0 | 1 | $-2 020 000 |
| Erica Rossitto | SVP & Chief Nurse Executive | 10 de febrero de 2026 F | 10 407 | 0 | 0 | $0 |
| Michael S. Cuffe | EVP and Chief Clinical Officer | 10 de febrero de 2026 F | 32 080 | 0 | 1 | $-747 135 |
| Sammie S Mosier | SVP & Chief Nurse Executive | 13 de febrero de 2025 F | 11 113 | 0 | 0 | $0 |
| Kathleen M Whalen | SVP & Chief Ethics Officer | 14 de noviembre de 2024 S | 9 454 | 0 | 0 | $0 |
| Phillip G Billington | SVP-Internal Audit Services | 12 de noviembre de 2024 M | 52 702 | 0 | 0 | $0 |
| Joseph A Sowell III | SVP; Chief Development Officer | 5 de agosto de 2024 G | 18 526 | 0 | 0 | $0 |
| Deborah M Reiner | SVP - Mktg. & Communications | 29 de julio de 2024 S | 3 510 | 0 | 0 | $0 |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 25 de julio de 2024 S | 17 755 | 0 | 0 | $0 |
| Jeffrey E. Cohen | SVP-Government Relations | 9 de mayo de 2024 S | 5 185 | 0 | 0 | $0 |
| Chad J Wasserman | SVP and CIO | 18 de marzo de 2024 M | 1 576 | 0 | 0 | $0 |
| Martin P. Paslick | SVP and CIO | 12 de abril de 2023 M | 24 643 | 0 | 0 | $0 |
| Jane D. Englebright | SVP and Chief Nursing Officer | 9 de noviembre de 2021 S | 0 | 0 | 0 | $0 |
| Robert A Waterman | SVP & General Counsel | 5 de mayo de 2021 S | 50 062 | 0 | 0 | $0 |
| William J Morrow | SVP - Finance and Treasurer | 18 de febrero de 2021 F | 5 578 | 0 | 0 | $0 |
| Sandra L. Morgan | SVP-Provider Relations | 18 de febrero de 2021 F | 10 122 | 0 | 0 | $0 |
| Victor L Campbell | SVP-Government Affairs | 1 de mayo de 2019 A | 194 145 | 0 | 0 | $0 |
| John M Steele | SVP & Chief Human Res. Officer | 25 de febrero de 2019 M | 84 157 | 0 | 0 | $0 |
| Milton R Johnson | Chairman | 25 de febrero de 2019 M | 881 823 | 0 | 0 | $0 |
| Ravi S. Chari | SVP-Clinical Excellence | 25 de febrero de 2018 M | 7 003 | 0 | 0 | $0 |
| Alan R Yuspeh | SVP & Chief Ethics Officer | 25 de febrero de 2018 M | 35 546 | 0 | 0 | $0 |
| Joseph N Steakley | SVP-Internal Audit Services | 25 de febrero de 2018 M | 65 199 | 0 | 0 | $0 |
| Jana Joustra Davis | SVP - Mktg. & Corp. Affairs | 23 de mayo de 2017 M | 26 378 | 0 | 0 | $0 |
| David Gwin Anderson | SVP - Finance | 7 de noviembre de 2016 M | 110 167 | 0 | 0 | $0 |
| Donald W Stinnett | SVP & Controller | 25 de febrero de 2016 A | 51 965 | 0 | 0 | $0 |
| Noel B Williams | SVP and CIO | 16 de mayo de 2012 M | 299 030 | 0 | 0 | $0 |
| Jack O Bovender JR | Chairman | 6 de octubre de 2009 A | 188 340 | 0 | 0 | $0 |
| Carl V George | SVP - Development | 27 de febrero de 2009 M | 13 092 | 0 | 0 | $0 |
| Patricia T Lindler | SVP - Government Programs | 17 de noviembre de 2006 D | 0 | 0 | 0 | $0 |
| Rosalyn S Elton | SVP-Operations Finance | 17 de noviembre de 2006 D | 0 | 0 | 0 | $0 |
| Frank M Houser MD | SVP-Quality & Medical Director | 26 de julio de 2006 A | 46 145 | 0 | 0 | $0 |
| James A Fitzgerald JR | SVP-Supply Chain Operations | 29 de enero de 2006 F | 20 674 | 0 | 0 | $0 |
| Andrea B Smith | Consejero | 28 de abril de 2026 A | 4 666 | 0 | 0 | $0 |
| William R Frist | Consejero | 28 de abril de 2026 A | 13 740 | 0 | 0 | $0 |
| Wayne Joseph Riley | Consejero | 28 de abril de 2026 A | 15 029 | 0 | 0 | $0 |
| Hugh F Johnston | Consejero | 28 de abril de 2026 A | 4 475 | 0 | 0 | $0 |
| Thomas F Frist III | Consejero | 28 de abril de 2026 A | 15 858 | 0 | 0 | $0 |
| Michael W Michelson | Consejero | 28 de abril de 2026 A | 12 576 | 0 | 0 | $0 |
| Nancy Ann Deparle | Consejero | 28 de abril de 2026 A | 21 910 | 0 | 0 | $0 |
| John Chidsey | Consejero | 28 de abril de 2026 A | 1 305 | 0 | 0 | $0 |
| Robert J Dennis | Consejero | 29 de abril de 2025 A | 26 601 | 0 | 0 | $0 |
| Meg Crofton | Consejero | 29 de abril de 2024 A | 6 331 | 0 | 0 | $0 |
| Charles O Holliday JR | Consejero | 25 de abril de 2022 A | 18 955 | 0 | 0 | $0 |
| Geoffrey G Meyers | Consejero | 1 de mayo de 2019 A | 39 153 | 0 | 0 | $0 |
| John W Rowe | Consejero | 1 de mayo de 2019 A | 30 388 | 0 | 0 | $0 |
| Ann H Lamont | Consejero | 2 de mayo de 2018 A | 17 661 | 0 | 0 | $0 |
| Jay O Light | Consejero | 3 de mayo de 2017 A | 30 953 | 0 | 0 | $0 |
| Stephen G Pagliuca | Consejero | 5 de diciembre de 2014 D | 7 612 921 | 0 | 0 | $0 |
| Christopher R Gordon | Consejero | 1 de noviembre de 2013 D | 30 003 156 | 0 | 0 | $0 |
| John Connaughton | Consejero | 1 de noviembre de 2013 D | 30 003 156 | 0 | 0 | $0 |
| John H Mcarthur | Consejero | 17 de noviembre de 2006 D | 0 | 0 | 0 | $0 |
| Kent C Nelson | Consejero | 17 de noviembre de 2006 D | 0 | 0 | 0 | $0 |
| Magdalena Averhoff MD | Consejero | 17 de noviembre de 2006 D | 0 | 0 | 0 | $0 |
| Glenda A Hatchett | Consejero | 17 de noviembre de 2006 D | 0 | 0 | 0 | $0 |
| Frederick W Gluck | Consejero | 17 de noviembre de 2006 D | 0 | 0 | 0 | $0 |
| Harold T Shapiro | Consejero | 17 de noviembre de 2006 D | 0 | 0 | 0 | $0 |
| Michael C Armstrong | Consejero | 17 de noviembre de 2006 D | 0 | 0 | 0 | $0 |
| Martin Feldstein | Consejero | 17 de noviembre de 2006 D | 0 | 0 | 0 | $0 |
| Michael T Long | Consejero | 17 de noviembre de 2006 D | 0 | 0 | 0 | $0 |
| ROYAL FRANK S | Consejero | 17 de noviembre de 2006 D | 0 | 0 | 0 | $0 |
| Patricia F Elcan | Propietario del 10% | 6 de febrero de 2026 J | 36 557 141 | 0 | 0 | $0 |
| Frisco Holding II | Propietario del 10% | 6 de febrero de 2026 J | 36 557 141 | 0 | 0 | $0 |
| HERCULES HOLDING II, LLC | Propietario del 10% | 6 de febrero de 2026 J | 32 282 889 | 0 | 0 | $0 |
| Thomas F Frist JR | Propietario del 10% | 6 de febrero de 2026 J | 36 557 141 | 0 | 0 | $0 |
| Patricia C Frist | Propietario del 10% | 20 de febrero de 2018 G | 0 | 0 | 0 | $0 |
| KKR PEI GP LTD | Propietario del 10% | 1 de abril de 2014 J | 0 | 0 | 0 | $0 |
| Jonathan B Perlin | · | 2 de agosto de 2021 S | 44 348 | 0 | 0 | $0 |
| Juan Vallarino | · | 9 de mayo de 2016 M | 61 036 | 0 | 0 | $0 |
| Richard M Bracken | · | 31 de diciembre de 2014 F | 82 499 | 0 | 0 | $0 |
| BANK OF AMERICA CORP /DE/ | · | 6 de noviembre de 2012 S | 2 652 364 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 141 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BUL · Pacer Funds Trust | 5,07% | 16 545 NS | 31 de julio de 2026 | N-PORT |
| IHF · iShares Trust | 4,75% | 147 977 SH | 11 de septiembre de 2026 | Diario |
| STNC · Hennessy Funds Trust | 3,17% | 7 315 NS | 31 de julio de 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 2,50% | 97 403 SH | 1 de octubre de 2026 | Diario |
| COWZ · Pacer Funds Trust | 2,07% | 960 711 NS | 31 de julio de 2026 | N-PORT |
| WLTG · ETF Opportunities Trust | 2,06% | 3 942 NS | 31 de julio de 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,65% | 33 803 SH | 1 de octubre de 2026 | Diario |
| RPG · Invesco Exchange-Traded Fund Trust | 1,30% | 58 562 SH | 1 de octubre de 2026 | Diario |
| FLAG · Global X Funds | 1,14% | 48 NS | 31 de julio de 2026 | N-PORT |
| FCPI · FIDELITY COVINGTON TRUST | 1,03% | 6 909 NS | 31 de julio de 2026 | N-PORT |
| IYH · iShares Trust | 1,01% | 87 417 SH | 11 de septiembre de 2026 | Diario |
| SRHQ · Elevation Series Trust | 0,94% | 4 938 NS | 31 de julio de 2026 | N-PORT |
| NEAR · iShares U.S. ETF Trust | 0,92% | 48 109 000 SH | 11 de septiembre de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,91% | 74 445 NS | 31 de julio de 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,90% | 470 451 SH | 19 de agosto de 2026 | Diario |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,87% | 22 725 NS | 31 de julio de 2026 | N-PORT |
| DIVB · iShares Trust | 0,87% | 42 100 SH | 11 de septiembre de 2026 | Diario |
| NFRA · FlexShares Trust | 0,84% | 62 628 NS | 31 de julio de 2026 | N-PORT |
| IXJ · iShares Trust | 0,83% | 81 708 SH | 11 de septiembre de 2026 | Diario |
| SPVM · Invesco Exchange-Traded Fund Trust | 0,81% | 2 483 SH | 1 de octubre de 2026 | Diario |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,79% | 3 522 NS | 31 de julio de 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,78% | 23 458 000 | 1 de octubre de 2026 | Diario |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,74% | 25 897 000 | 1 de octubre de 2026 | Diario |
| CURE · Direxion Shares ETF Trust | 0,72% | 3 056 NS | 31 de julio de 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,67% | 12 075 SH | 19 de agosto de 2026 | Diario |
| LGDX · Tidal Trust III | 0,66% | 2 345 NS | 31 de julio de 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,55% | 11 876 SH | 19 de agosto de 2026 | Diario |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,50% | 22 893 000 | 1 de octubre de 2026 | Diario |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0,46% | 7 404 NS | 31 de julio de 2026 | N-PORT |
| WLDR · Two Roads Shared Trust | 0,43% | 964 NS | 31 de julio de 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0,42% | 7 289 NS | 31 de julio de 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,41% | 92 254 SH | 1 de octubre de 2026 | Diario |
| QLC · FlexShares Trust | 0,39% | 9 856 NS | 31 de julio de 2026 | N-PORT |
| XOEF · iShares Trust | 0,37% | 194 SH | 11 de septiembre de 2026 | Diario |
| GSY · Invesco Actively Managed Exchange-T… | 0,36% | 14 000 000 | 1 de octubre de 2026 | Diario |
| UPSD · ETF Series Solutions | 0,33% | 972 NS | 31 de julio de 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,33% | 9 324 000 | 1 de octubre de 2026 | Diario |
| MGV · VANGUARD WORLD FUND | 0,29% | 97 604 SH | 19 de agosto de 2026 | Diario |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,28% | 390 000 | 1 de octubre de 2026 | Diario |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,28% | 3 186 NS | 31 de julio de 2026 | N-PORT |
| USXF · iShares Trust | 0,26% | 9 226 SH | 11 de septiembre de 2026 | Diario |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,26% | 5 803 SH | 1 de octubre de 2026 | Diario |
| IWX · iShares Trust | 0,23% | 21 535 SH | 11 de septiembre de 2026 | Diario |
| VTV · VANGUARD INDEX FUNDS | 0,23% | 1 475 731 SH | 19 de agosto de 2026 | Diario |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,23% | 14 235 NS | 31 de julio de 2026 | N-PORT |
| MPLY · Strategy Shares | 0,22% | 87 NS | 31 de julio de 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,21% | 9 589 SH | 11 de septiembre de 2026 | Diario |
| RSP · Invesco Exchange-Traded Fund Trust | 0,21% | 463 744 SH | 1 de octubre de 2026 | Diario |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,20% | 6 420 NS | 31 de julio de 2026 | N-PORT |
| SIZE · iShares Trust | 0,19% | 1 920 SH | 11 de septiembre de 2026 | Diario |
| DYNF · BlackRock ETF Trust | 0,19% | 183 934 SH | 11 de septiembre de 2026 | Diario |
| VMAX · Lattice Strategies Trust | 0,19% | 228 NS | 31 de julio de 2026 | N-PORT |
| DSI · iShares Trust | 0,19% | 23 734 SH | 11 de septiembre de 2026 | Diario |
| ILCV · iShares Trust | 0,18% | 5 870 SH | 10 de septiembre de 2026 | Diario |
| IVW · iShares Trust | 0,18% | 331 185 SH | 11 de septiembre de 2026 | Diario |
| IUSG · iShares Trust | 0,17% | 136 713 SH | 11 de septiembre de 2026 | Diario |
| VOOG · VANGUARD ADMIRAL FUNDS | 0,17% | 115 334 SH | 19 de agosto de 2026 | Diario |
| IWD · iShares Trust | 0,17% | 332 035 SH | 11 de septiembre de 2026 | Diario |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,16% | 17 845 SH | 1 de octubre de 2026 | Diario |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,16% | 90 157 SH | 19 de agosto de 2026 | Diario |
| USMV · iShares Trust | 0,16% | 89 855 SH | 11 de septiembre de 2026 | Diario |
| ACWV · iShares, Inc. | 0,15% | 11 903 SH | 11 de septiembre de 2026 | Diario |
| EGLE · Global X Funds | 0,15% | 8 NS | 31 de julio de 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0,15% | 4 NS | 31 de julio de 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,15% | 33 327 SH | 1 de octubre de 2026 | Diario |
| VOXP · Advisors Series Trust | 0,13% | 18 NS | 31 de julio de 2026 | N-PORT |
| VRIG · Invesco Actively Managed Exchange-T… | 0,12% | 2 250 000 | 1 de octubre de 2026 | Diario |
| TOPC · iShares Trust | 0,12% | 95 SH | 11 de septiembre de 2026 | Diario |
| DGRO · iShares Trust | 0,12% | 120 741 SH | 11 de septiembre de 2026 | Diario |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,11% | 4 392 SH | 1 de octubre de 2026 | Diario |
| XVV · iShares Trust | 0,11% | 1 790 SH | 11 de septiembre de 2026 | Diario |
| IWL · iShares Trust | 0,11% | 5 786 SH | 11 de septiembre de 2026 | Diario |
| MGC · VANGUARD WORLD FUND | 0,11% | 31 176 SH | 19 de agosto de 2026 | Diario |
| ACIO · ETF Series Solutions | 0,11% | 6 205 NS | 31 de julio de 2026 | N-PORT |
| EVUS · iShares Trust | 0,10% | 934 SH | 11 de septiembre de 2026 | Diario |
| ADME · ETF Series Solutions | 0,10% | 751 NS | 31 de julio de 2026 | N-PORT |
| XRMI · Global X Funds | 0,10% | 126 NS | 31 de julio de 2026 | N-PORT |
| XCLR · Global X Funds | 0,10% | 9 NS | 31 de julio de 2026 | N-PORT |
| XYLD · Global X Funds | 0,10% | 8 148 NS | 31 de julio de 2026 | N-PORT |
| XTR · Global X Funds | 0,10% | 12 NS | 31 de julio de 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,10% | 26 763 SH | 1 de octubre de 2026 | Diario |
| BKLC · BNY Mellon ETF Trust | 0,10% | 13 621 NS | 31 de julio de 2026 | N-PORT |
| VV · VANGUARD INDEX FUNDS | 0,10% | 181 364 SH | 19 de agosto de 2026 | Diario |
| ESGV · VANGUARD WORLD FUND | 0,10% | 33 758 SH | 19 de agosto de 2026 | Diario |
| IVV · iShares Trust | 0,10% | 1 957 485 SH | 11 de septiembre de 2026 | Diario |
| PTLC · Pacer Funds Trust | 0,10% | 7 919 NS | 31 de julio de 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,10% | 1 395 NS | 31 de julio de 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,10% | 877 SH | 1 de octubre de 2026 | Diario |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 1 791 SH | 1 de octubre de 2026 | Diario |
| ILCB · iShares Trust | 0,10% | 2 915 SH | 11 de septiembre de 2026 | Diario |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,09% | 20 766 NS | 31 de julio de 2026 | N-PORT |
| IYY · iShares Trust | 0,09% | 6 693 SH | 11 de septiembre de 2026 | Diario |
| VOTE · TCW ETF Trust | 0,09% | 2 545 NS | 31 de julio de 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,09% | 3 614 NS | 31 de julio de 2026 | N-PORT |
| XYLG · Global X Funds | 0,09% | 147 NS | 31 de julio de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,09% | 46 791 NS | 31 de julio de 2026 | N-PORT |
| IWB · iShares Trust | 0,09% | 103 721 SH | 11 de septiembre de 2026 | Diario |
| VOO · VANGUARD INDEX FUNDS | 0,09% | 4 034 357 SH | 19 de agosto de 2026 | Diario |
| TOV · EA Series Trust | 0,09% | 607 NS | 31 de julio de 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,09% | 586 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,09% | 202 387 SH | 11 de septiembre de 2026 | Diario |
| ACVF · ETF Opportunities Trust | 0,09% | 337 NS | 31 de julio de 2026 | N-PORT |
| GTOS · Invesco Actively Managed Exchange-T… | 0,09% | 104 000 | 1 de octubre de 2026 | Diario |
| QDPL · Pacer Funds Trust | 0,09% | 3 708 NS | 31 de julio de 2026 | N-PORT |
| IWV · iShares Trust | 0,09% | 41 034 SH | 11 de septiembre de 2026 | Diario |
| DFAU · Dimensional ETF Trust | 0,08% | 25 516 NS | 31 de julio de 2026 | N-PORT |
| CRBN · iShares Trust | 0,08% | 2 269 SH | 11 de septiembre de 2026 | Diario |
| PHDG · Invesco Actively Managed Exchange-T… | 0,08% | 116 SH | 1 de octubre de 2026 | Diario |
| TOK · iShares Trust | 0,08% | 451 SH | 11 de septiembre de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,08% | 4 930 930 SH | 19 de agosto de 2026 | Diario |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,08% | 24 633 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,08% | 12 577 SH | 19 de agosto de 2026 | Diario |
| HCMT · Direxion Shares ETF Trust | 0,08% | 1 081 NS | 31 de julio de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,08% | 4 108 NS | 31 de julio de 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0,07% | 12 141 NS | 31 de julio de 2026 | N-PORT |
| URTH · iShares, Inc. | 0,07% | 14 079 SH | 11 de septiembre de 2026 | Diario |
| ACWI · iShares Trust | 0,06% | 50 294 SH | 11 de septiembre de 2026 | Diario |
| HDUS · Lattice Strategies Trust | 0,05% | 275 NS | 31 de julio de 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,05% | 125 729 SH | 19 de agosto de 2026 | Diario |
| DCOR · Dimensional ETF Trust | 0,05% | 3 816 NS | 31 de julio de 2026 | N-PORT |
| GLOF · iShares Trust | 0,04% | 202 SH | 11 de septiembre de 2026 | Diario |
| DUHP · Dimensional ETF Trust | 0,04% | 10 761 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 28 662 NS | 31 de julio de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,02% | 1 127 NS | 31 de julio de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 99 NS | 31 de julio de 2026 | N-PORT |
| GTO · Invesco Actively Managed Exchange-T… | 0,00% | 42 000 | 30 de septiembre de 2026 | Diario |
| CBLS · Elevation Series Trust | -1,12% | -1 546 NS | 31 de julio de 2026 | N-PORT |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 de julio de 2026 | Diario |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 de julio de 2026 | Diario |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 de julio de 2026 | Diario |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 de julio de 2026 | Diario |
| VUSB · VANGUARD BOND INDEX FUNDS | · | · | 15 de julio de 2026 | Diario |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15 de julio de 2026 | Diario |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15 de julio de 2026 | Diario |
| VSDB · VANGUARD MALVERN FUNDS | · | · | 15 de julio de 2026 | Diario |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 de julio de 2026 | Diario |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 de julio de 2026 | Diario |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 de julio de 2026 | Diario |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 de julio de 2026 | Diario |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 de julio de 2026 | Diario |
| VCEB · VANGUARD WORLD FUND | · | · | 30 de julio de 2026 | Diario |
HCA Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
Precio objetivo a 12 meses
22 analistas · 2026-09-28Objetivo medio $454.23 +6,5%
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | · |
| THC | $17.28B | 12.8 | 3.1% | 11.1% | 56.4% | · |
| EHC | $10.61B | 19.2 | 10.5% | 9.5% | 25.1% | · |
| UHS | · | 9.4 | 9.7% | 8.6% | 21.4% | · |
| ENSG | $10.12B | 29.8 | 18.7% | 6.8% | 16.9% | · |
| PACS | $6.01B | 31.5 | 29.3% | 3.6% | 23.1% | · |
| CON | $2.53B | 15.1 | 13.9% | 7.7% | 49.8% | · |
| BKD | $2.57B | -9.6 | 2.2% | -8.2% | -313.2% | 26.2% |
| ACHC | $1.28B | -1.2 | 5.0% | -33.3% | -43.9% | · |
| SNDA | $612M | -7.7 | 25.2% | -18.6% | -197.2% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Señales de trading Señales recientes de compra/venta con precio de entrada y ratio riesgo/recompensa
Ninguna señal abierta en este momento — ninguna tarjeta está completada, y eso es honesto.
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.